Benign Prostatic Hyperplasia (BPH)

πŸ‘΄πŸ½ Benign Prostatic Hyperplasia (BPH)

NP Student Educational Guide


βœ… Definition

Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland, commonly seen in aging men. It leads to lower urinary tract symptoms (LUTS) due to urethral compression and bladder outlet obstruction.


πŸ“Š Epidemiology

  • Very common in men >50 years old

  • ~50% of men by age 60

  • ~90% by age 85

  • Not all men with BPH develop symptoms


🧬 Pathophysiology

  • BPH involves hyperplasia of prostatic stromal and epithelial cells, mostly in the transition zone.

  • Androgens (especially dihydrotestosterone, DHT) drive prostate growth.

  • As the prostate enlarges, it compresses the urethra, leading to bladder outflow obstruction and urinary symptoms.


🚽 Clinical Presentation

LUTS = Lower Urinary Tract Symptoms
πŸ”Ή Voiding (Obstructive) Symptoms:
  • Weak urinary stream

  • Hesitancy

  • Straining

  • Incomplete emptying

  • Intermittency

  • Dribbling

πŸ”Ή Storage (Irritative) Symptoms:
  • Urgency

  • Frequency

  • Nocturia

  • Urge incontinence (less common)

πŸ“Œ Hematuria or UTIs may occur with chronic retention.


πŸ“ History & Physical Exam

πŸ” History:
  • Symptom onset and severity

  • Impact on quality of life

  • Medication use (anticholinergics, decongestants)

  • Voiding pattern, nocturia, incontinence

πŸ‘¨πŸ½β€βš•οΈ Physical Exam:
  • Digital Rectal Exam (DRE):

    • Enlarged, smooth, firm, nontender prostate

    • Nodules β†’ rule out prostate cancer

  • Abdominal exam for bladder distension


πŸ§ͺ Diagnostic Workup

Test

Purpose

UA (Urinalysis)

Rule out UTI or hematuria

PSA (optional)

Screen for prostate cancer (controversial in BPH)

Serum creatinine

Check renal function if retention is suspected

Post-void residual (PVR)

Bladder scan or cath after voiding

IPSS (International Prostate Symptom Score)

Symptom assessment (mild, moderate, severe)


πŸ›  Management

πŸ”Ή 1. Watchful Waiting
  • For mild symptoms (IPSS 0–7)

  • Lifestyle changes:

    • Limit fluids before bed

    • Avoid caffeine/alcohol

    • Timed voiding

    • Avoid decongestants and anticholinergics

πŸ”Ή 2. Pharmacologic Therapy

Class

Example

Mechanism

Notes

Alpha-1 blockers

Tamsulosin, Terazosin

Relax prostate/bladder neck smooth muscle

Fast symptom relief in days

5-alpha reductase inhibitors

Finasteride, Dutasteride

Shrink prostate by blocking DHT

Takes months; ↓ PSA by 50%

Combination therapy

Tamsulosin + Finasteride

Dual benefit for larger prostates

Better long-term outcomes

Anticholinergics

Oxybutynin

Reduce bladder irritability

Use if irritative symptoms dominate

Beta-3 agonists

Mirabegron

Improve bladder capacity

Alternative to anticholinergics

⚠ Always assess post-void residual before starting anticholinergics β€” risk of retention.

πŸ”Ή 3. Surgical Options

Consider if:

  • Failed medical therapy

  • Recurrent urinary retention

  • Recurrent UTIs or bladder stones

  • Hematuria or hydronephrosis from BPH

Procedures include:

  • TURP (transurethral resection of prostate) – gold standard

  • Laser therapy

  • UroLift or Rezum – newer, minimally invasive options


🚩 When to Refer to Urology

  • Gross hematuria

  • Elevated PSA

  • Abnormal DRE (nodules)

  • Recurrent urinary retention or UTIs

  • Renal impairment due to obstruction

  • Failure of medical management


πŸ‘©β€βš• NP’s Role

  • Identify symptoms early

  • Educate patients on lifestyle modifications

  • Initiate and monitor medication therapy

  • Monitor for complications (retention, hematuria)

  • Collaborate with urology when needed


🧠 Clinical Pearl

A sudden worsening of urinary symptoms in a man with BPH may be due to:

  • UTI

  • Medication side effects (antihistamines, anticholinergics)

  • Bladder stones

  • Prostate cancer